Skip to content

Spinalanæstesi til knæartroskopi: Kan tilsætning af Lidokain til Bupivacain forkorte blokadens varighed?

Spinalanæstesi til knæartroskopi: Kan tilsætning af Lidokain til Bupivacain forkorte blokadens varighed?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-011828-64-DK
Enrollment
Unknown
Registered
2009-06-17
Start date
2009-08-03
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duration of nerve blockade after spinal anesthesia with either bupivacaine or a mixture of bupivacaine/lidocaine.

Interventions

Trade Name: Bupivacaine (Marcain). Product Name: Marcaine Product Code: Marcaine Pharmaceutical Form: Solution for injection Trade Name: Lidocaine Product Name: Lidocaine Product Code: N 01 BB 02 Ph

Sponsors

Anesthesiological dep., Hospital of Frederikssund
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Planned unilateral knee-artroscopy under spinal anaesthesia, ASA-score 1 or 2, between 18 and 65 year old, between 155 and 190 cm at length and Body Mass Index below 35. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Contraindications for or not-wanting spinal anaesthesia.

Design outcomes

Primary

MeasureTime frame
Main Objective: The duration of sensoric and motoric blockade of spinal anaesthesia.;Secondary Objective: Time for patient discharged at home. ;Primary end point(s): Duration of sensoric and motoric blockade after spinal anaesthesia.

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026